| NCT06787144 | ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants | RECRUITING | PHASE1 | 2025-01-23 | 2028-01 | 2028-01 |
| NCT06328738 | ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-05-30 | 2028-07 | 2027-01 |
| NCT05650879 | ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 | 2023-03-20 | 2026-07 | 2026-07 |
| NCT05304377 | A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | RECRUITING | PHASE1 | 2022-05-22 | 2026-12 | 2026-12 |